(Q37374871)

20 August 2017

DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats (English)

1 reference

20 August 2017

0 references

0 references

H-X Yan

1

1 reference

20 August 2017

H-P Wu

2

1 reference

20 August 2017

H-L Zhang

3

1 reference

20 August 2017

C Ashton

4

1 reference

20 August 2017

C Tong

5

1 reference

20 August 2017

J Wu

6

1 reference

20 August 2017

Q-J Qian

7

1 reference

20 August 2017

H-Y Wang

8

1 reference

20 August 2017

Q-L Ying

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

15 October 2012

1 reference

20 August 2017

1 reference

20 August 2017

32

1 reference

20 August 2017

38

1 reference

20 August 2017

4565-4571

1 reference

Tumor promotion via injury- and death-induced inflammation

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Hallmarks of Cancer: The Next Generation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Production of p53 gene knockout rats by homologous recombination in embryonic stem cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

The first 30 years of p53: growing ever more complex

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Senescence of activated stellate cells limits liver fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Experimental models of hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Hepatocellular carcinoma pathogenesis: from genes to environment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

A model for p53-induced apoptosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Liver Carcinogenesis by Diethylnitrosamine in the Rat

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855850

2 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.451

Molecular pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FONC.2012.451

Hepatocarcinogenesis in p53-deficient mice

31 March 2020

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FONC.2012.451

Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23069657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.451

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

23069657

1 reference